GORDON; Lynn K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for GORDON; Lynn K..The latest application filed is for "treatment of cancers using anti-emp2 antibody and pd-1/pdl-1 pathway antagonist combination therapy".

Company Profile

2.10.14

GORDON; Lynn K. - Tarzana CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Cancers Using Anti-emp2 Antibody And Pd-1/pdl-1 Pathway Antagonist Combination Therapy App 20190352399 - WADEHRA; Madhuri ; et al.	2019-11-21
Anti-emp2 Therapy Reduces Cancer Stem Cells App 20190077852 - WADEHRA; Madhuri ; et al.	2019-03-14
Antibodies which bind to epithelial membrane protein 2 (EMP2) Grant 9,624,304 - Braun , et al. April 18, 2	2017-04-18
Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR) Grant 9,464,135 - Gordon , et al. October 11, 2	2016-10-11
Anti-emp2 Therapy Reduces Cancer Stem Cells App 20150329621 - WADEHRA; Madhuri ; et al.	2015-11-19
Emp2 Antibodies And Their Therapeutic Uses App 20150329641 - BRAUN; Jonathan ; et al.	2015-11-19
Methods of treating cancer by administering EMP2 antibodies Grant 9,011,857 - Braun , et al. April 21, 2	2015-04-21
Emp2 Regulates Angiogenesis In Cancer Cells Through Induction Of Vegf App 20150079089 - Wadehra; Madhuri ; et al.	2015-03-19
EMP2 antibodies and methods of use thereof for causing regression of a solid tumor or symptoms thereof Grant 8,785,602 - Braun , et al. July 22, 2	2014-07-22
EMP2 antibodies and methods of use thereof causing regression of a solid tumor or symptoms thereof Grant 8,779,104 - Braun , et al. July 15, 2	2014-07-15
Emp2 Antibodies And Their Therapeutic Uses App 20140072569 - BRAUN; Jonathan ; et al.	2014-03-13
Prevention of chlamydia infection using SIRNA Grant 8,648,052 - Braun , et al. February 11, 2	2014-02-11
Emp2 Antibodies And Their Therapeutic Uses App 20130344078 - BRAUN; Jonathan ; et al.	2013-12-26
Emp2 Antibodies And Their Therapeutic Uses App 20130230527 - BRAUN; Jonathan ; et al.	2013-09-05
Epithelial Membrane Protein 2 (emp2) Binding Reagents And Their Therapeutic Uses In Ocular Diseases App 20130034555 - Gordon; Lynn K. ; et al.	2013-02-07
Epithelial Membrane Protein-2 (emp2) And Proliferative Vitroretinopathy (pvr) App 20130004493 - Gordon; Lynn K. ; et al.	2013-01-03
EMP2 antibodies and their therapeutic uses Grant 8,318,906 - Braun , et al. November 27, 2	2012-11-27
Emp2 Antibodies And Their Therapeutic Uses App 20120020983 - Braun; Jonathan ; et al.	2012-01-26
Emp2 Antibodies And Their Therapeutic Uses App 20100272732 - Braun; Jonathan ; et al.	2010-10-28
Prevention Of Chlamydia Infection Using A Protective Antibody App 20080181889 - Braun; Jonathan ; et al.	2008-07-31
Nucleic acids for the diagnosis and treatment of giant cell arteritis Grant 6,743,903 - Gordon , et al. June 1, 2	2004-06-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.